Scientific article
English

Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment

Published inAmerican journal of ophthalmology, vol. 144, no. 2, p. 294-296
Publication date2007
Abstract

To evaluate pigment epithelium detachment (PED) secondary to exudative age-related macular degeneration (AMD) treated with intravitreal injection of bevacizumab with regard to incidence of retinal pigment epithelium tears (RIPs).

Keywords
  • Aged
  • Angiogenesis Inhibitors/administration & dosage/adverse effects/therapeutic use
  • Antibodies, Monoclonal/administration & dosage/adverse effects/therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Incidence
  • Injections
  • Male
  • Pigment Epithelium of Eye/drug effects/pathology
  • Retinal Detachment/drug therapy/pathology
  • Retinal Perforations/chemically induced/epidemiology/pathology
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Vascular Endothelial Growth Factor A
  • Visual Acuity
  • Vitreous Body
Affiliation entities Not a UNIGE publication
Citation (ISO format)
WEINBERGER, Andreas W A et al. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment. In: American journal of ophthalmology, 2007, vol. 144, n° 2, p. 294–296. doi: 10.1016/j.ajo.2007.03.024
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0002-9394
530views
0downloads

Technical informations

Creation21/09/2016 13:52:00
First validation21/09/2016 13:52:00
Update15/03/2023 00:59:24
Status update15/03/2023 00:59:23
Last indexation31/10/2024 05:11:45
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack